Organogenesis Holdings Inc.

ORGO · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$21,567-$9,392-$18,843$7,673
Dep. & Amort.$6,987$4,575$6,283$6,420
Deferred Tax-$3,837-$1,026-$1,266-$2,832
Stock-Based Comp.$0$2,542$3,367$0
Change in WC-$29,880-$38,120-$20,713-$6,779
Other Non-Cash$8,242$8,548$11,237$6,455
Operating Cash Flow$3,079-$32,873-$19,935$10,937
Investing Activities
PP&E Inv.-$2,235-$3,638-$3,626-$3,361
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$2,235-$3,638-$3,626-$3,361
Financing Activities
Debt Repay.-$296-$288-$285-$62,621
Stock Issued$130$0$25$121,751
Stock Repurch.$0$0$0-$25,479
Dividends Paid$0$0$0$0
Other Fin. Act.-$10,041$0-$1,796-$2
Financing Cash Flow-$10,207-$288-$2,056$33,649
Forex Effect$0$0$0$0
Net Chg. in Cash-$9,363-$36,799-$25,617$41,225
Supplemental Information
Beg. Cash$73,735$110,534$136,151$94,926
End Cash$64,372$73,735$110,534$136,151
Free Cash Flow$844-$36,511-$23,561$7,576
Organogenesis Holdings Inc. (ORGO) Financial Statements & Key Stats | AlphaPilot